On November 19, 2025, the Food and Drug Administration granted accelerated approval to Bayer’s (BAYRY) sevabertinib, a kinase inhibitor, for adults with locally advanced or metastatic, non-squamous ...
Coreen often arrives smiling and eager to our 10th-grade criminal-justice classroom in our rural high school. But when content moves too fast or there is a need for background knowledge she's still ...
As Arkansas educators hurry to maximize the number of third graders reading at grade level to meet a new requirement, AR Kids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback